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Cholangiocarcinoma and Sclerosing Cholangitis: Clinical 
Characteristics and Effect on Survival After Liver Transplantation 
K.M. Abu-Elmagd, R. Selby, S. Iwatsuki, J. Fung, A. Tzakis, S. Todo, A.J. Demetris, N. Baddour, W. Irish, 
D.H. Van Thiel, and T.E. Starzl 
ORTHOTOPIC liver transplantation (OLTx) has 
emerged during. the last decade to be the most 
effective therapy for patients with advanced primary scle-
rosing cholangitis (PSC).1-3 The potential risk of develop-
ing cholangiocarcinoma (CCA) in these patients triggered 
the current study to define the clinical characteristics of 
patients with concomitant CCA and its effect on patient 
survival after transplantation. 
MATERIALS AND METHODS 
Patient Population 
Over a period of9 years (December 1981 to December 1990),169 
adult patients with the diagnosis of advanced PSC underwent 
OLTx at the University of Pittsburgh Medical Center. Eighteen of 
these 169 consecutive patients were found to have a concomitant 
CCA, with an incidence of 10.6%. The diagnosis of CCA was 
known preoperatively in only 7 patients (38.9%). Standard total 
hepatectomy was performed, with the exception of I case of upper 
abdominal exenteration. The primary immunosuppressive drug 
was cyclosporine in 81% and FK 506 in 19% of the patients. 
Adjuvant radiotherapy and chemotherapy were given before 
and/or after transplantation in II patients. 
Statistical Analysis 
The sex, presence or absence of inflammatory bowel disease 
(IBD), and histologic stage of PSC' were compared in patients 
with PSC alone and those with PSC and CCA using Pearson's 
chi-square test of association. The age, duration of both IBD and 
liver disease, and the pretransplant serum bilirubin, alkaline 
phosphatase. and ,},"GTP were also compared using two-tailed 
Student's t test. The survival curves were generated using the 
Kaplan-Meier method and were compared utilizing the general-
ized Wilcoxon (Breslow) test. 
RESULTS 
The age, gender, duration of liver disease, presence or 
absence and duration of IBD, and histologic stage of PSC 
were similar for patients with PSC alone and those with 
PSC and CCA (P > .05). Also, there was no significant 
difference between the two groups comparing the pretrans-
plant serum bilirubin, alkaline phosphatase, and -y-GTP 
levels (P > .05). 
A thorough histologic examination of the hepatectomy 
specimen revealed the coexistence of CCA in II patients in 
addition to the 7 who were diagnosed before OLTx. The 
tumor was intrahepatic in 2 patients (11.1%). hilar in 13 
(72.2%), and involving gallbladder or cystic duct in 3 
(16.7%). Tumor was at the resection margin in 6 cases 
(33%) and hilar lymph nodes were positive in 3 (16.7%). 
The tumor cells were well differentiated in I 1 patients 
(61%). Patients with incidental CCA had a slightly higher 
incidence of positive resection margins (36.4%) than did 
those diagnosed before OLTx (28.6%). 
The mean (±SD) post-OLTx follow-up time for all 
patients was 43 ± 29 months (range, 0 to 117 months). The 
I-year survival rate for patients with PSC alone was 85% 
compared to 72% with PSC and CCA, and the survival 
rates at 5 years were 75.8% and 26.7%, respectively (P = 
.0001). The total mortality rate with prediagnosed CCA 
(85.7%) was higher than with incidental tumors (54.5%) 
and the actuarial 2-year survival rates were 28.6% and 
54.6%, respectively (P = .37). The median survival time 
was 14 months for the prediagnosed CCA patients and 23 
months for the incidental group. Only one patient in the 
prediagnosed group is still alive with no evidence of 
recurrence 26 months after OLTx. In the incidental group 
5 patients are still alive, free of tumor 23 to 73 months after 
transplantation. 
DISCUSSION 
The risk of developing CCA in patients with PSC has been 
previously documented by different centers.5-7 The total 
incidence of CCA in the PSC patients who underwent 
OLTx over 9 years at our institute was 10.6%. Although 
this estimate of prevalence may have been influenced by a 
referral bias to our transplant center, a similar incidence 
has been reported by other centers.5-9 The epidemiologic. 
pathogenic, and immunologic mechanisms of such associ-
ation have yet to be defined. 
The current diagnostic tools are inadequate for early 
detection of CCA occurring in the setting of PSC. This is 
demonstrated in the current study by the high incidence of 
failure to diagnose CCA before transplantation (61.1%), 
despite an active attempt to do so. Comparing the preoper-
ative data, there were no clinical distinctions between 
patients with PSC and CCA and those with PSC alone. 
Similar to other studies, no other laboratory features 
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reliably distinguished patients with CCA in the setting of 
PSC. S.8 Also. the histologic stage of PSC did not correlate 
with the presence of CCA. 
The presence of CCA in patients with PSC markedly 
reduces survival after OLTx. In this and earlier reports 
published from our center. 3,10 the diagnosis or detection of 
CCA in PSC patients significantly influences the long-term 
outcome after transplantation. However. patients with 
incidental CCA have a better survival rate after OLTx 
compared to those identified before transplantation. 
It is clear from these data that CCA occurring in the 
setting of PSC is nearly always detected at an advanced 
stage of the disease that precludes a cure after OLTx for 
most patients. In conclusion. (1) cholangiocarcinoma ad-
versely influences the survival of patients transplanted for 
PSC and (2) patients with a preoperative diagnosis of CCA 
do worse than those with incidental CCA. An obvious 
need for better diagnostic tools for CCA exists in patients 
with PSc. 
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